-
How Sanofi COVID-19 Vaccine Candidates are Designed2021-03-25LL -
SCIENCE & INNOVATIONAccelerating Genomic Medicine at Sanofi2021-03-15LL -
-
SCIENCE & INNOVATIONHow Registries Accelerate Rare Disease Research2021-03-12LL -
-
SCIENCE & INNOVATIONTaking Down Type 2 Inflammatory Disease2020-11-30LL -
-
-
SCIENCE & INNOVATIONMetabolic Hub May Offer New Hope for Rare Diseases2020-10-20LL -
SCIENCE & INNOVATIONHow Multiple Sclerosis Affects the Brain2020-09-11LL -
SCIENCE & INNOVATIONThe Science Behind Sanofi's Hemophilia Pipeline2020-09-10LL -
YOUR HEALTHVaccines: our best line of defense against infectious diseases like COVID-192020-07-27LL -
-
ABOUT USIdentifying a New Target to Address an old challenge: CEACAM5 and Lung Cancer2020-06-15LL -
ABOUT USSupporting Scientific Progress Through Clinical Trials2020-05-20LL -
SCIENCE & INNOVATIONSanofi Researchers Turn a Hunch into a Clinical Study for Rare Diseases2020-02-24LL -
#SanofiActsSanofi’s Two Vaccine Candidates against COVID-19 -
-
Manufacturing vaccines is a complex journey -
SCIENCE & INNOVATIONTargeting estrogen receptors in breast cancer
